Meta facebook tracking pixel

Listen Now

Topics Covered

  • Discussion of Myelodysplastic Syndromes (MDS)
  • Diagnosis, Staging & Current Standard of Care
  • The Role of Hematopathology Examination of a Sample of Your Bone Marrow in Making a Definitive Diagnosis of MDS
  • New & Emerging Treatment Approaches
  • The Role of Clinical Trials: How Research Increases Your Treatment Options
  • Tips to Manage Symptoms, Treatment Side Effects, Discomfort, Pain & Quality-of-Life Concerns
  • Nutrition & Hydration Concerns & Tips
  • Key Questions to Ask Your Health Care Team During Telehealth Appointments
  • Guidelines to Prepare for Telehealth Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Next Steps After Treatment, Including Follow-up Care in Collaboration with Your Primary Care Doctor & Team
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Srinivasa R. Sanikommu, MD

Assistant Professor, Wake Forest School of Medicine, Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute, Advocate Health

Presenter

Nilay Shah, MD

Assistant Professor, Cancer Medicine (Charlotte), Wake Forest University School of Medicine, Associate Fellowship Program Director, Medical Director of Education, Hematology/Oncology, Atrium Health Wake Forest Baptist Advocate Health

Presenter

Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center

Presenter

Ashley Moncrief, RN, BSN

Director of Patient Care, MDS Foundation Inc.

Presenter

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on November 24, 2025.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top